Pimecrolimus is an ascomycin-derived calcineurin inhibitor primarily used in the treatment of atopic dermatitis and various inflammatory skin conditions by modulating T-cell activation. To support stringent… Read more


















Pimecrolimus is an ascomycin-derived calcineurin inhibitor primarily used in the treatment of atopic dermatitis and various inflammatory skin conditions by modulating T-cell activation. To support stringent quality control and drug development, this category offers a comprehensive selection of Pimecrolimus reference standards. Pharmaceutical laboratories utilize these high-quality compounds, including the active pharmaceutical ingredient, to perform precise impurity profiling and analytical method validation. The range encompasses pharmacopeial and non-pharmacopeial impurities, such as specific epi-derivatives, tautomers, and desmethyl metabolites, which are essential for identifying degradation products and monitoring manufacturing consistency. Additionally, stable isotope-labelled compounds are available to serve as internal standards in quantitative mass spectrometry workflows. By providing these critical materials, the collection facilitates accurate assessment and regulatory compliance throughout the lifecycle of the drug.